ATLASNurix Therapeutics (NRIX) earnings date: expected January 3–9
Nurix Therapeutics (NRIX) has not announced its next earnings date yet. Based on its last 3 reports, ATLAS expects it around January 3–9. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on NRIX
| Last price | $25.70 (-4.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.9% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Nurix Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 3–9 (estimate). One email the day before, with ATLAS’s read on Nurix Therapeutics. You can switch it off at any time.
Alert me before NRIX reportsFree to start. Creating an account takes under a minute.
Notify me when Nurix Therapeutics reports
Track NRIX free Add Nurix Therapeutics to a free ATLAS watchlist and see its next report date in one place.
NRIX earnings at a glance
| Next report | Not announced · expected around January 3–9 (ATLAS estimate) |
|---|---|
| Last report | Oct 12, 2026 · Beat |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | +189.5% |
| Average move around a report | ±2.1% (last 5) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between Nurix Therapeutics’s last 3 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Nurix Therapeutics earnings history: last 5 reports
Nurix Therapeutics last reported on Oct 12, 2026: EPS of $4.73 against an estimate of -$0.56 (+944.6% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 12, 2026 | -$0.56 | $4.73 | +944.6% | Beat | -1.1% |
| Aug 21, 2026 | $4.03 | $4.73 | +17.4% | Beat | -2.9% |
| Jul 9, 2026 | -$0.72 | -$0.81 | -12.5% | Miss | -5.1% |
| Apr 24, 2026 | $1.56 | $1.59 | +1.9% | In line | -0.5% |
| Apr 8, 2026 | -$0.76 | -$0.79 | -3.9% | Miss | -0.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for NRIX
See the fair value, the probability range and the earnings history of Nurix Therapeutics on its ATLAS page.
Nurix Therapeutics (NRIX) stock analysisPlans from €3.99 a month.
Nurix Therapeutics earnings: frequently asked questions
When is Nurix Therapeutics (NRIX) next earnings date?
Nurix Therapeutics has not announced its next report. Its last 3 reports came Oct 12, 2026, Jul 9, 2026, Apr 24, 2026, so ATLAS estimates the next one around January 3–9. This is an estimate based on that pattern, not a confirmed date.
How often does NRIX beat earnings estimates?
Of its last 5 reports with a recorded result, Nurix Therapeutics beat the EPS estimate 2 times; the average surprise was +189.5%. Past results do not predict the next one.
How much does NRIX move around earnings?
Over its last 5 reports the stock moved an average of 2.1% (absolute, from the close before the report day to the close after it), and finished higher 0 of 5 times.
Did Nurix Therapeutics beat earnings estimates last quarter?
Nurix Therapeutics last reported on Oct 12, 2026: EPS of $4.73 against an estimate of -$0.56 (+944.6% surprise), a beat.
How much does NRIX usually move in a day?
On a normal trading day the ATLAS model puts NRIX’s one-day range at about ±2.9%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer